Himmelfarb Health Sciences Library, The George Washington University

Health Sciences Research Commons
Pharmacology and Physiology Faculty Publications

Pharmacology and Physiology

1-2016

Structure of the polyisoprenyl-phosphate
glycosyltransferase GtrB and insights into the
mechanism of catalysis
Chiara Ardiccioni
Oliver B. Clarke
David Tomasek
Habon A. Issa
George Washington University

Desiree C. von Alpen
George Washington University
See next page for additional authors

Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_pharm_facpubs
Part of the Medical Pharmacology Commons, and the Medical Physiology Commons
Recommended Citation
Ardiccioni, C., Clarke, O.B., Tomasek, D., Issa, H.A., von Alpen, D.C., Pond, H.L., ...Mancia, F. (2016). Structure of the polyisoprenylphosphate glycosyltransferase GtrB and insights into the mechanism of catalysis. Nature Communications, 7:10175. doi:10.1038/
ncomms10175

This Journal Article is brought to you for free and open access by the Pharmacology and Physiology at Health Sciences Research Commons. It has been
accepted for inclusion in Pharmacology and Physiology Faculty Publications by an authorized administrator of Health Sciences Research Commons.
For more information, please contact hsrc@gwu.edu.

Authors

Chiara Ardiccioni, Oliver B. Clarke, David Tomasek, Habon A. Issa, Desiree C. von Alpen, Heather L. Pond,
M. Chiara Manzini, and +11 additional authors

This journal article is available at Health Sciences Research Commons: https://hsrc.himmelfarb.gwu.edu/smhs_pharm_facpubs/105

ARTICLE
Received 8 Oct 2015 | Accepted 11 Nov 2015 | Published 5 Jan 2016

DOI: 10.1038/ncomms10175

OPEN

Structure of the polyisoprenyl-phosphate
glycosyltransferase GtrB and insights
into the mechanism of catalysis
Chiara Ardiccioni1,*, Oliver B. Clarke2,*, David Tomasek1, Habon A. Issa3,4, Desiree C. von Alpen3,4,
Heather L. Pond3,4, Surajit Banerjee5, Kanagalaghatta R. Rajashankar5, Qun Liu6, Ziqiang Guan7, Chijun Li7,
Brian Kloss8, Renato Bruni8, Edda Kloppmann9,10, Burkhard Rost9,10, M. Chiara Manzini3,4, Lawrence Shapiro2
& Filippo Mancia1

The attachment of a sugar to a hydrophobic polyisoprenyl carrier is the ﬁrst step for
all extracellular glycosylation processes. The enzymes that perform these reactions,
polyisoprenyl-glycosyltransferases (PI-GTs) include dolichol phosphate mannose synthase
(DPMS), which generates the mannose donor for glycosylation in the endoplasmic reticulum.
Here we report the 3.0 Å resolution crystal structure of GtrB, a glucose-speciﬁc PI-GT from
Synechocystis, showing a tetramer in which each protomer contributes two helices to a
membrane-spanning bundle. The active site is 15 Å from the membrane, raising the question
of how water-soluble and membrane-embedded substrates are brought into apposition
for catalysis. A conserved juxtamembrane domain harbours disease mutations, which
compromised activity in GtrB in vitro and in human DPM1 tested in zebraﬁsh. We hypothesize
a role of this domain in shielding the polyisoprenyl-phosphate for transport to the active site.
Our results reveal the basis of PI-GT function, and provide a potential molecular explanation
for DPM1-related disease.
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I

n humans and bacteria alike, the ﬁrst step in all glycosylation
reactions that take place in outer cellular compartments
involves the attachment of a sugar in the cytoplasm to a
hydrophobic carrier molecule to generate a sugar donor molecule
for transmembrane (TM) export1. In eukaryotes, such donors are
necessary for processes including N- and O-linked protein
glycosylation and glycophosphatidylinositol anchoring. In
Gram-negative bacteria, they contribute to the biosynthesis of
the cell wall, and its modiﬁcations that underlie serotype
conversion, a bacterial mechanism for evasion of the host
immune response2. Sugar attachment to hydrophobic carrier
molecules for transport across membranes is catalysed by
polyisoprenyl-glycosyltransferases (PI-GTs), integral membrane
enzymes conserved across all kingdoms of life3. Bacterial PI-GTs
utilize undecaprenyl-phosphate (UndP) as the sugar carrier,
whereas their eukaryotic and archaeal counterparts use the related
dolichol phosphate (DolP)3. Mutations in the human PI-GT
dolichol phosphate mannose synthase (DPMS) catalytic subunit
DPM1 (refs 4,5)—the enzyme that charges DolP with mannose
for protein glycosylation—cause congenital disorders of
glycosylation1,6–8 type 1e resulting in severe phenotypes
including developmental delay and vascular abnormalities9.
PI-GTs have a predicted two-domain architecture composed of
a cytosolic amino-terminal catalytic domain and a TM region, but
their functional assemblies, detailed structures and catalytic
mechanisms remain unknown.
Here we report the ﬁrst structure and functional characterization of a representative PI-GT, GtrB from Synechocystis sp.
PCC6803 (ref. 10; GtrBSyn) to 3.0 Å resolution. We describe
enzyme assays that show that recombinant GtrBSyn expressed in
Escherichia coli attaches a glucose molecule to UndP, a key
reaction for immune evasion by aggressive pathogens such as
Shigella ﬂexneri and Salmonella enterica11,12. GtrB is a tetramer in
which each protomer contributes two TM helices to a membranespanning bundle. The soluble glycosyltransferase (GT) domains

are separated from the TM helices by a juxtamembrane region
that positions the active site 15 Å below the membrane surface.
This structure, together with results of functional mutagenesis on
GtrBSyn and human DPM1 in a zebraﬁsh model, provides the
framework to understand how PI-GTs work in both prokaryotes
and eukaryotes.
Results
Crystallization and structure determination. To determine the
structure of a representative member of the PI-GT family,
we followed a structural genomics approach, and screened 45
prokaryotic PI-GTs, identiﬁed via a bioinformatics analysis, for
expression in E. coli and stability in detergents amenable to
crystallization13. GtrBSyn, the PI-GT from Synechocystis sp.
PCC6803, was the most promising. Indeed, we produced
crystals of this protein, in the detergent n-decyl-b-Dmaltopyranoside (DM), which diffracted X-rays anisotropically
to 3.2/3.6 Å resolution. We determined this structure by multicrystal single-wavelength anomalous diffraction (SAD)14 analysis
of the selenomethionine-substituted protein. Subsequently,
although probing the function of the enzyme with structurebased mutagenesis, we produced crystals of the point mutant
F215A, which fortuitously diffracted isotropically to 3.0 Å,
allowing us to improve the quality of the model (Table 1).
F215A, which resides in a functionally relevant region of the
protein, has compromised catalytic activity (Supplementary
Table 1), but the structures are essentially identical, and unless
indicated otherwise, we show here the better F215A model.
Functional characterization of GtrB from Synechocystis. GtrB
was initially identiﬁed in bacteriophage-infected Shigella ﬂexneri
strains in a cluster of genes that mediate serotype conversion by
glucosylating- and acetylating-speciﬁc residues in the O-antigen
of the cell wall11,15. GtrB is a bona ﬁde PI-GT as it carries out the

Table 1 | Data collection and reﬁnement statistics.

Wavelength (Å)
Resolution range (Å)
Space group
Unit cell
a
b
c
b
Total reﬂections
Unique reﬂections
Multiplicity
Completeness (%)
Mean I/sigma(I)
Wilson B-factor
Rmerge
CC1/2
Rwork
Rfree
Number of non-hydrogen atoms
Macromolecules
Ligands
RMS (bonds)
RMS (angles)
Ramachandran favoured (%)
Ramachandran outliers (%)
Clashscore

SeMet-GtrB*
0.979
46.79–3.21 (3.40–3.10)
C2
155.866
138.771
101.048
98.249
863,961 (105,225)
38,430 (4,716)
22.5 (22.3)
98.8 (99.3)
21.5 (1.2)
105.4
0.123 (3.55)
0.997 (0.519)
—
—
—
—
—
—
—
—
—
—

GtrB
0.979
19.99–3.194 (3.308–3.194)
C2
157.331
137.518
101.448
98.5
260,786 (24,889)
35,029 (3,408)
7.4 (7.3)
98.0 (97.0)
12.84 (1.32)
125.7
0.089 (1.32)
0.999 (0.684)
0.220 (0.321)
0.279 (0.374)
9,254
9,150
104
0.009
1.19
90
0.86
14.95

GtrB (F215A)
0.979
40.79–3.0 (3.107–3.0)
C2
154.159
142.263
102.024
97.158
182,341 (17,880)
43,375 (4,247)
4.2 (4.2)
98.0 (98.0)
17.65 (0.99)
112.6
0.045 (1.30)
0.997 (0.692)
0.249 (0.389)
0.276 (0.415)
9,243
9,139
104
0.004
0.54
94
0.52
5.77

GtrB (WO4)
1.02
37.82–4.498 (4.658–4.498)
C2
155.858
141.618
101.463
97.99
98,386 (9,396)
13,024 (1,282)
7.6 (7.3)
99.0 (99.0)
7.81 (2.32)
195.8
0.180 (1.71)
0.998 (0.763)
—
—
—
—
—
—
—
—
—
—

Statistics for the highest resolution shell are shown in parentheses.
*Friedel pairs (I þ /I  ) treated as separate reﬂections; RMS, Root mean square.
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Figure 1 | GtrB catalyses the formation of UndP-glucose in vivo and in vitro. (a) GtrB (TM domain in blue, GT domain in orange) catalyses the
transfer of a glucose from UDP-glucose to UndP, producing UndP-glucose. (b) Cells overexpressing GtrB accumulate a species detected by negative ion
ESI/MS at m/z of 1,007.75, corresponding to the [M-H]-ion of UndP-glucose. Its identity was further conﬁrmed by tandem mass spectrometry (MS/MS).
(c) When incubated with varying concentrations of UndP for 1 h, membranes prepared from GtrB-overexpressing cells accumulate UndP-glucose
(UndP-Glc) in a concentration-dependent manner (circles), whereas those prepared from control cells overexpressing a membrane protein of unrelated
function do not (squares). Error bars are provided as ±s.e.m., n ¼ 3.

ﬁrst step in the glucosylation process, generating UndP-glucose
on the cytoplasmic face of the inner membrane (Fig. 1a), which is
later utilized as a glucose donor during glucosylation of the
O-antigen. To assess the PI-GT function of the enzyme from
Synechocystis, we performed mass spectrometry on lipid extracts
from E. coli cells overexpressing GtrBSyn, revealing speciﬁc
accumulation of UndP-glucose (Fig. 1b). In vitro assays on
GtrBSyn, monitoring the UndP-speciﬁc accumulation of 14C in a
water-insoluble phase from UDP-14C-glucose also conﬁrmed
the synthesis of UndP-glucose from UDP-glucose and UndP
(Fig. 1c).
The structural architecture of GtrB. The structure shows that
GtrBSyn is a tetramer (Fig. 2a,b), with each protomer consisting
of an N-terminal cytosolic GT domain of the GT-A fold16,
a juxtamembrane region, two TM helices (TM1 and TM2), which
form a compact stalk anchoring the intracellular domains to the
membrane, and a short C-terminal beta-hairpin (Fig. 2c–f and
Supplementary Fig. 1). The short beta-hairpin at the C-terminus
bridges the interaction between adjacent subunits in the tetramer
(Supplementary Fig. 2). Two amphipathic juxtamembrane helices
(JM1 and JM2; Fig. 2c–f and Supplementary Fig. 1) lie at the
cytoplasmic surface of the membrane, oriented parallel to one
another, and sharing a hydrophobic interface (Supplementary
Fig. 3). JM1 is located in an internal loop in the GT domain,
whereas JM2 is an N-terminal extension of TM1 (Supplementary
Fig. 1) analogous to the ‘slide helix’ found in potassium channel
structures17. JM1 was ﬁrst identiﬁed by analysis of the predicted
secondary structure18, which suggested the presence of a

conserved amphipathic helix located in the b5-6 loop and
spanning residues 130–146. Although the density in this region is
poorer than in other regions of the map (Supplementary Figs 4
and 5a), the presence of two methionine residues helped conﬁrm
the register of the sequence using selenomethionine-labelled
protein crystals (Supplementary Fig. 5b).
Despite unambiguous experimental density for the majority
of the molecule, electron density for the periplasmic loop
that connects the TM helices is poor, leading to two possible
topologies for subunit association in the tetramer (Supplementary
Fig. 6). Based on our interpretation of the maps, we believe the
most probable topology results in the C-terminal short betahairpin forming close interactions with the originating protomer
(Supplementary Fig. 6a), rather than with the adjacent one
(Supplementary Fig. 6b). The coordinates we have deposited
leaves this ambiguity unresolved, with the protomer divided into
two chains. However, for the sake of clarity, all ﬁgures showing
the GtrBSyn structure depict the topology we judge to be most
probable.
Donor and acceptor sites in GtrB. GtrBSyn crystals were typically
soaked in UDP-glucose before cryoprotection and freezing, as this
step led to better resolution and reproducibility in the quality of
the diffraction pattern. This soaking step had the additional
advantage of allowing us to speciﬁcally identify the monosaccharide donor site. The UDP-glucose donor substrate binds in
a shallow cleft on the surface of the cytosolic GT domain, in a
similar position to that determined in other structures of GT-A
fold GTs19 (Fig. 3a). A divalent cation mediates the interaction
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Figure 2 | Architecture of GtrB, an integral membrane PI-GT. The tetrameric assembly of GtrB, in which each of the four polypeptide chains is
represented as a ribbon drawn in a different colour, is shown here (a) from a position orthogonal to the TM helices and (b) looking down the fourfold
symmetry axis of the tetramer from the extracellular side. (c) A single protomer is shown. The protomer is comprised of a GT-A fold GT domain (orange),
two amphipathic juxtamembrane helices (grey; juxtamembrane (JM)), two TM helices (blue) and a C-terminal b-hairpin (red). (d,e) The GtrB tetramer is
shown in the same two views and orientations as in a,b, with three subunits represented in grey ribbons and the fourth in rainbow colouring from the
N-terminus (blue) to the C-terminus (red). (f) The GtrB monomer shown in the same orientation as in c, represented in rainbow colouring from the
N-terminus (N; blue) to the C-terminus (C; red).

between the diphosphate of the UDP and a signature DXD
motif20 (94Dx96D in GtrBSyn). The anomalous signal of
manganese soaked into the crystals was used to positively
identify the ion-binding site although magnesium appears to be
preferred for optimal activity of the enzyme (Supplementary
Fig. 7a). Despite the fact that UDP-glucose was soaked into the
crystals immediately before cryoprotection and freezing,
interpretable density was only observed for the UDP
(Supplementary Fig. 7b), indicating that the glucose is either
poorly ordered or was hydrolysed before data collection, as has
previously been observed for other GTs21.
To identify the UndP acceptor site, we performed anomalous
diffraction experiments with a GtrBSyn crystal soaked with
tungstate, a phosphate analogue with a larger X-ray anomalous
scattering signal (Fig. 3a and Supplementary Fig. 8). Remarkably,
the anomalous difference density overlays perfectly with
the position expected from structural alignments with other
GT-acceptor complexes from soluble enzymes of the GT-A fold
(Supplementary Fig. 9a).
In the 3.0 Å resolution structure without tungstate, we cannot
see side chain density for R122, and the segment between R197
and N208, and the limited resolution (4.5 Å) of the data with
tungstate does not allow us to reliably assign previously
disordered sequence in the map.
However, we can hypothesize that R122 and R200, which are
universally conserved among prokaryotic and eukaryotic GTs
that process lipid-phosphate acceptors (Supplementary Fig. 9b),
will coordinate the acceptor. Mutation of either of these two
arginines to glutamine or alanine severely compromised GtrBSyn
activity, suggesting that they play an important role in binding
the phosphate of the acceptor (Fig. 3b).
4

The chemistry of catalysis. The transfer of a sugar group to the
acceptor molecule can occur with either inversion or retention of
the stereochemistry at the anomeric carbon. The corresponding
two classes of GTs are known as inverting and retaining,
respectively22. Overall, the data suggest that GtrB is an inverting
GT, based both on previous sequence-based classiﬁcation and
the shallow, solvent-exposed nature of the active site seen in the
GtrBSyn structure, a feature typical of inverting GTs23. The
mechanism of catalysis, while broadly similar to that described
for other inverting GTs, differs in detail due to the nature of the
acceptor24. Unlike most GTs, which attach a saccharide donor at
a neutral, protonated hydroxyl on the acceptor substrate, GtrB
catalyses the attachment of glucose to the phosphate oxygen,
which is expected to be deprotonated under physiological
conditions. A key step in the reaction mechanism of
conventional inverting GTs involves the participation of a
catalytic base residue, which abstracts a proton from the
acceptor, enabling nucleophilic attack by the resultant lone pair
of electrons at the anomeric carbon24,25. When the acceptor is
already deprotonated, it is unclear whether this step is necessary,
and it seems likely that the role of a catalytic acid residue in
assisting hydrolysis of the UDP-sugar donor will be more
prominent. Based on structural alignment with other GT-A fold
GTs and mutagenesis data showing that GtrBSyn activity is
abolished in the D157N mutant (Fig. 3b), we identiﬁed D157 as a
putative catalytic acid, and propose a tentative scheme for how
the reaction catalysed by GtrB may take place, and describe it
here in the context of the GtrBSyn structure (Fig. 3c).
Bringing substrates into apposition for catalysis to occur. The
active site of GtrBSyn is located in the cytosol B15 Å from the
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Figure 3 | The catalytic mechanism of GtrB. (a) The disposition of key residues in the active site and interactions with the acceptor and donor substrates.
An anomalous difference Fourier map (contoured at 5 s above the mean) calculated from a tungstate-soaked wild-type (WT) crystal is represented as
purple mesh. Residues D94, D96, R122, D157, R200 and the UDP are shown in stick representation. Mn2 þ is represented as a purple sphere. (b) Mutation
of key residues in the acceptor and donor sites abolishes GtrB activity. (c) The catalytic mechanism of GtrB does not require a catalytic base. Error bars are
provided as s.e.m., n ¼ 3.

membrane (Supplementary Fig. 11). This raises the question
of how the hydrophobic acceptor from the membrane and
hydrophilic donor from the cytosol are brought into proximity
for catalysis to occur; that is, whether the GT domain moves to
the membrane, or whether the lipid-phosphate acceptor is
translocated to the active site. We favour the latter mechanism for
three reasons. First, B900 Å2 of predominantly hydrophobic
surface is buried between each pair of GT domains in the cytosol,
with eight inter-subunit hydrogen bonds and two salt bridges
formed at each interface (Supplementary Fig. 2), suggesting a
stable structure that is unlikely to disassemble for the GT domain
to move to the membrane. Second, the enzyme is highly speciﬁc
for acceptors built from isoprenyl units (Supplementary Fig. 10),
but the lack of strong conservation in the TM region
(Supplementary Fig. 11) suggests that speciﬁcity for the lipid may
reside elsewhere in the protein. Third, we have identiﬁed several
absolutely conserved hydrophobic and basic residues in the juxtamembrane region (Supplementary Figs 11 and 12a) that could
in principle form a solvent-shielded pathway for translocation of
substrate from the membrane to the active site where the acceptor
phosphate is bound by the side chains of R122 and R200 (Fig. 4a–
c). Functional requirements for these residues (Fig. 4d), and their
conserved pattern (Supplementary Figs 11 and 12a), lead us to
put forth the hypothesis that as the UndP diffuses along this
pathway, with its isoprenyl groups shielded by the hydrophobic
residues, the phosphate headgroup could form transient ionic

interactions with the positively charged moieties of the basic
residues (Fig. 4a–c). To investigate this hypothesis, we ﬁrst produced GtrBSyn with mutations at each of the conserved residues
R122, R125, K132, A136, Y140, R200, L212, A216 and R290, in
the juxtamembrane region. Mutations at any of these sites led a
complete loss of enzymatic activity (Fig. 4d). However, the
mutant proteins could be expressed, solubilized and puriﬁed in a
non-ionic detergent at levels comparable to wild type, with a
similar elution proﬁle in size-exclusion chromatography, suggesting that the overall structure was unaffected (Supplementary
Fig. 13). As further proof that the fold of GtrBSyn was unaffected
by mutagenesis, we crystallized and determined the structure of
several of these point mutants (Y209A, L212F, A216M, A136M,
R122Q, T135A, R145A). Finally, functional assays on single-point
mutations of each of the residues of JM1 and JM2 to alanine show
that the entire region is extremely sensitive to even minor
perturbations in structure (Supplementary Fig. 14), highlighting
the importance of the juxtamembrane region in GtrB function.
GtrB as a structural model to study DPMS function. Although
PI-GTs have high sequence variability, and they may consist of
one or multiple chains, the overall architecture comprising a
soluble GT domain, a juxtamembrane region composed of two
amphipathic helices and one or more TM segments is conserved.
The TM region of the human DPMS complex is composed of two
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Figure 4 | A putative mechanism for substrate translocation in GtrB and DPM1 function in a zebraﬁsh model. (a) A speculative hypothesis is that the
phosphate headgroup of UndP (red) could ﬁrst bind at R290, near the cytoplasmic face of the inner membrane. (b) The substrate could then diffuse along a
pathway lined with conserved hydrophobic (teal) and positively charged (blue) residues. (c) Finally, the phosphate headgroup is coordinated by R122 and
R200 at the acceptor site, where catalysis occurs. (d) Mutation of hydrophobic and positively charged conserved residues lining the region between JM1
and JM2 abrogates GtrB activity. Error bars are provided as s.e.m., n ¼ 3. (e) The architecture of GtrB may be shared by the DPMS complex. CDG1e
mutations G152V and S248P in the conserved JM1 and JM2 linkers are represented in purple and red, respectively. (f) Phenotypes typical of dpm1 loss-offunction mutations are fully evident at 2 days post fertilization (d.p.f.) in the zebraﬁsh embryo. Morphants show smaller head (microcephaly) and smaller
eyes, kinked tail and occasional vascular defects in the tail vein (arrowhead). Scale bar, 500 mm (g) Functional analysis of DPM1 mutants was performed by
injecting human DPM1 mRNA following dpm1 morpholino injection and embryos were scored as normal or affected. Human DPM1 mRNA was able to
improve the morphant phenotypes (see Supplementary Fig. 8f for details) and the effect of different mutations was normalized to rescue levels. mRNA
carrying the R147A or R234A mutations (equivalent to R122 and R200 in GtrB, respectively) showed almost complete loss of function. Known human
missense changes (R92S, G152V and S248P) were also tested. R92S and G152V greatly abolished protein function, whereas S248P, which leads to milder
human phenotypes, showed substantial residual activity. The presumed location of G152V and S248P on the juxtamembrane region is shown. R92S is
expected to reside close to the active site in the GT domain. Error bars: s.e.m., **Po0.01, ***Po0.001, unpaired Student’s t-test for each mutant, n ¼ 6
(R147A), n ¼ 6 (R234A), n ¼ 3 (R92S), n ¼ 5 (G152V), n ¼ 4 (S248P). NS, not signiﬁcant.

separate polypeptide chains, but there is high conservation in the
key functional residues in the juxtamembrane region we have
identiﬁed here (Supplementary Fig. 12a). Interestingly, diseasecausing mutations G152V and S248P in human DPM1, the
catalytic subunit of the DPMS complex, have been mapped to the
JM1-GT and JM2-GT linkers, and are conserved in GtrB (Fig. 4e
and Supplementary Fig. 12b)26,27. Another disease mutant, R92S,
which causes the most severe phenotype, is expected to be located
close to the active site. Together, these observations lead us to
suggest that DPMS and other PI-GTs are likely to function by
similar mechanisms. To investigate this hypothesis, we performed
assays to determine whether GtrB and DPMS shared functional
similarities. First, we asked whether GtrB could attach its donor
substrate to DolP, the acceptor used by DPMS and all other
eukaryotic PI-GTs. Indeed, GtrBSyn could readily glucosylate
DolP (Supplementary Fig. 12c). Second, we generated a zebraﬁsh
model of dpm1 loss of function by knocking-down dpm1 in
zebraﬁsh fertilized oocytes using two independent morpholino
antisense oligonucleotides (MOs) targeting either translation
6

(start site) or transcription (donor splice site in exon 1) at 4 and
8 ng, respectively. MO concentrations were carefully titrated to
avoid nonspeciﬁc binding effects observed with high MO
concentration, and knockdown was measured by quantitative
PCR (Supplementary Fig. 15a,b). A scrambled control MO was
used at equal concentrations to show that the effects were speciﬁc
to dpm1 (Supplementary Fig. 15c). Identical phenotypes were
observed for both MOs and dpm1 morphants recapitulated most
features of congenital disorder of glycosylation type 1e (CDG1e)
associated with DPM1 mutations, including developmental delay,
microcephaly, ocular defects and vascular anomalies, which were
fully evident at 2–3 days post fertilization (d.p.f.; Fig. 4f and
Supplementary Fig. 15d,e)9. Injection of human DPM1 mRNA
was able to signiﬁcantly rescue the dpm1 morphant phenotypes
showing that the function is conserved between humans and
zebraﬁsh, and that the phenotypes observed are due to the loss of
dpm1 (Supplementary Fig. 15f). Injection of DPM1 mRNA alone
had no effect on development (Supplementary Fig. 15g). To test
whether the proposed mechanisms of action is plausible in

NATURE COMMUNICATIONS | 7:10175 | DOI: 10.1038/ncomms10175 | www.nature.com/naturecommunications

ARTICLE

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10175

human DPM1, we co-injected MO with mRNA carrying
mutations in R147 and R234, which correspond to R122 and
R200 in GtrBSyn. The mutant mRNAs failed to rescue dpm1
knockdown, suggesting that these residues are critical for function
(Fig. 4g). Finally, we tested all known human mutations, R92S,
G152V and S248P, which lead to variable phenotypic
presentations. As observed for wild-type DPM1, overexpression
of mutated mRNA alone had no effect indicating that these
missense changes do not generate a gain of function
(Supplementary Fig. 15g). R92S and G152V, which cause severe
CDG1e, showed severe loss of function, as was previously shown
in enzymatic assays9,26, whereas S248P, which causes a milder
version of the disease27, only partially affected DPM1 function
(Fig. 4g). Interestingly, a similar trend in activity levels was
observed in GtrBSyn for the G127V (inactive) and T205P
(partially inactive) mutants (Supplementary Fig. 12d).
Discussion
The structure of GtrB from Synechocystis sp. determined here at
3.0 Å resolution, is the ﬁrst for a representative PI-GT, enzymes
that attach a sugar to a lipid carrier for use in glycosylation
reactions3. GtrBs, including GtrBSyn, attach a glucose molecule to
UndP11,12, the conserved sugar-carrier lipid in prokaryotes
(Fig. 1). The structure shows that GtrB is a tetramer in which
each protomer has two membrane-spanning helices with a
catalytic domain similar to those of soluble GTs attached through
a juxtamembrane region (Fig. 2). Although the catalytic GT
domain and the JM region are conserved across the family, it
remains unclear whether other PI-GTs will have similar TM
topologies.
Similarities in the catalytic domain with other GT-A fold GTs,
coupled to functional mutagenesis data on GtrBSyn, have allowed
us to identify a conserved aspartic acid (D157) as putative
catalytic acid (Fig. 3b), and propose a scheme for how the
reaction catalysed by GtrB may take place (Fig. 3c).
In the GtrBSyn structure, the GT domains of the tetramer are
B15 Å distant from the membrane surface (Supplementary
Fig. 11), and separated from it by the juxtamembrane region. This
arrangement raises the question of how hydrophobic substrates
originating from the membrane and hydrophilic substrates from
the cytosol are brought into apposition for catalysis. Overall our
results, including the apparent rigidity of the assembly between
the four catalytic domains of the tetramer (Supplementary Fig. 2)
and functional loss by mutations in the juxtamembrane region
(Fig. 4d and Supplementary Fig. 14), favour a mechanism where
hydrophobic polyisoprenyl-phosphates translocate from the
membrane to the cytosolic-active site (Fig. 4a–c), although
further studies will be required to understand the molecular
details of this mechanism.
The sequence conservation we observe suggests that all PI-GTs
are likely to function similarly. The GtrB structure, together with
results of functional mutagenesis on this enzyme and on the
human DPM1 in a zebraﬁsh model, also presented here (Fig. 4e–g
and Supplementary Fig. 14), provide a framework for understanding PI-GT structure and function in both prokaryotes and
eukaryotes.

lower case letters indicate vector-speciﬁc sequences. The ampliﬁed product was
cloned into the expression vector pMCSG7 by ligation-independent cloning,
introducing a hexahistidine tag and a tobacco etch virus (TEV) protease cleavage
site at the N-terminus of the polypeptide30. The identity of the resulting construct
was veriﬁed by DNA sequencing. Sequence alignments were performed using
PRALINE and PROMALS-3D (refs 31,32). All point mutants were prepared using
the QuikChange site-directed mutagenesis kit (Agilent).
Protein expression and puriﬁcation. To produce both native and the
selenomethionine-substituted protein, GtrBSyn was overexpressed in E. coli strain
BL21 (DE3) pLysS. Cells were grown in 2xYT medium containing 100 mg ml  1
ampicillin and 50 mg ml  1 chloramphenicol at 37 °C. At an OD600 value of 0.8,
temperature was reduced to 22 °C and protein expression induced 15 min later
with the addition of 0.2 mM isopropyl b-D-thiogalactopyranoside. When producing
the selenomethionine-substituted protein, the protocol was the same aside from the
following. Cells were grown in minimal media containing M9 salts (M9 SeMET
High-Yield Growth Media Kit, Shanghai Medicilon Inc.) with a supplemental
150 mg of selenomethionine per litre of culture, and protein expression was
induced with 0.4 mM isopropyl b-D-thiogalactopyranoside. The puriﬁcation
protocol, as described below, is the same for both native and the selenomethioninesubstituted protein. Cells were harvested after overnight induction, then
re-suspended in lysis buffer (20 mM Na-HEPES, pH 7.5, 150 mM NaCl,
20 mM MgSO4, 10 mg ml  1 DNase I, 10 mg ml  1 RNase A, 1 mM
tris(2-carboxyethyl)phosphine (TCEP), 1 mM phenylmethanesulfonylﬂuoride and
Complete Mini EDTA-free protease inhibitor cocktail (Roche) as described in the
instructions. Cells were lysed using an Avestin Emulsiﬂex C3 homogenizer, and
then solubilized for 1 h by addition of (Anagrade, Affymetrix) to 1% (w/v) in a
typical volume of 50 ml for a pellet from an 800 ml growth culture. After pelleting
insoluble debris by ultracentrifugation (134,000g, 30 min) and ﬁltering the
supernatant (0.22 mm), solubilized GtrBSyn was puriﬁed by metal-afﬁnity followed
by size-exclusion chromatography (SEC) using a 24-ml Superose 12 column
(GE Healthcare). The SEC buffer contained 20 mM HEPES, pH 7.0, 150 mM NaCl,
1 mM TCEP and 0.2% (w/v) DM. Before crystallization, the peak fractions from
SEC were concentrated typically to 15 mg ml  1 (estimated from A280 nm) using a
centrifugal concentrator (Millipore) with a molecular weight cutoff of 50 kDa.
Approximately 2 mg of puriﬁed GtrBSyn could be obtained starting from an 800-ml
bacterial culture. Small-scale expression tests were performed by essentially the
same protocol as for the larger-scale puriﬁcation, starting from 80 mg of a cell pellet
taken from a larger-scale protocol. For small-scale expression tests, cells were lysed
by sonication.
Crystallization. Initial crystals were obtained by sitting drop vapour diffusion at
22 °C. The optimized crystallization protocol involved dispensing 600 nl of the
puriﬁed protein solution (15 mg ml  1) and 300 nl of reservoir solution (containing
16-18% PEG600 (v/v), 0.12 M Tris/HCl, pH 9.0, 0.1 M NaCl and 1 mM TCEP)
under 1 ml of silicone oil, in 96-well Axygen sitting-drop plates. Crystals typically
appeared after 1–2 days and grew to a ﬁnal size of B150 mm in each dimension.
Before cryoprotection, a reservoir solution containing 5 mM MnCl2 and 25 mM
UDP-glucose was added to the crystal-containing drop for 1 h. The crystals used
for the tungstate anomalous difference Fourier map were soaked overnight in
reservoir solution containing 10 mM sodium tungstate before cryoprotection.
Crystals were ﬂash-frozen by immersion in liquid nitrogen after incubating brieﬂy
in reservoir solution containing 28% (v/v) PEG600. Crystals of the native and the
selenomethionine-substituted protein typically diffracted anisotropically to
3.2–3.8 Å resolution. GtrBSyn crystallizes in space group C2, with unit cell
parameters (Å) a ¼ 157.3, b ¼ 137.5, c ¼ 101.4, b ¼ 98.5°. One tetramer is in the
asymmetric unit. Crystals of the F215A mutant were produced in the same way and
diffracted isotropically to 3.0 Å resolution.
Diffraction data collection and processing. Diffraction data were collected on
beamline X4C at the NSLS, Brookhaven National Laboratory, and on beamline
24-ID-C at the Advanced Photon Source. Data sets collected above the Se K-edge
from four selenomethionine-substituted crystals were merged and used for
structure solution at 3.2 Å by multi-crystal SAD14. The data were indexed,
integrated, scaled and merged using XDS and XSCALE33. Selenium sites were
located using SHELXD, and reﬁned in SHARP34. Density modiﬁcation, including
solvent ﬂattening, histogram matching and four-fold non-crystallographic
symmetry averaging, was performed using DM to give an initial experimentally
phased electron density map35.

Methods
Target identiﬁcation and mutagenesis. GtrB from the cyanobacterium
Synechocystis sp. PCC 6803 (UniProt, accession # Q55487) was initially identiﬁed
as a promising candidate for crystallization experiments by the NYCOMPS
(New York Consortium on Membrane Protein Structure) high-throughput target
identiﬁcation and screening pipeline28,29. The open reading frame encoding GtrB
was ampliﬁed by PCR using Synechocystis sp. PCC 6803 genomic DNA as template.
Primers used for ampliﬁcation were 50 -tacttccaatccaatgccACCATTGAACTGTCTA
TTGTGATT-30 (forward) and 50 -ttatccacttccaatgCTAATTAAGTTTTTCCAATG
GCAAA-30 (reverse), where upper case letters indicate gene-speciﬁc sequences and

Model building and reﬁnement. An initial model was built using the auto-tracing
option of SHELXE, and improved using BUCCANEER36–38. This model was
manually completed using COOT and reﬁned using the PHENIX crystallographic
software package, alternating between cycles of manual building in COOT and
reﬁnement in PHENIX39,40. Translation/Libration/Screw (TLS) parameterization
was employed in the latter stages of reﬁnement (using phenix.ﬁnd_tls_groups to
generate Translation/Libration/Screw (TLS) group boundaries), and riding
hydrogens were included in the last cycle of reﬁnement. Torsion-angle noncrystallographic symmetry restraints were used throughout reﬁnement. The ﬁnal
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models have an R/Rfree of 0.2281/0.2595 (WT) and 0.2685/0.3044 (F215A). A
snapshot of typical electron density in the ﬁnal 2mFo-DFc map is included as well
as the anomalous difference map derived from selenomethionine-labelled wild-type
crystals used for phasing and sequence registration (Supplementary Fig. 5). The
quality of the ﬁnal models was analysed using the validation module of the
PHENIX package, which incorporates Molprobity clash score, density correlation
and rotamer analysis41. For F215A, 93% of residues are in the favoured region of
the Ramachandran plot, with 0.3% outliers. Full data collection and reﬁnement
statistics are given in Supplementary Table 1. Protein structure ﬁgures were
prepared using UCSF Chimera42. Calculations of the surface area buried at the
subunit interfaces were performed using the PISA interface in COOT43.
Mass-spectrometry analysis of lipids. The procedures for lipid extraction
and liquid chromatography-mass spectrometry analysis were previously
described44. Brieﬂy, lipids were extracted from whole-cell samples (of either
GtrBSyn-overexpressing cells or a negative control expressing an unrelated
membrane protein) using a neutral Bligh-Dyer method45. After extraction, the
dried lipids were dissolved in chloroform/methanol (2:1(v/v)). The extracted lipid
species were separated by normal phase liquid chromatography (LC) using an
Ascentis Silica HPLC column. LC eluents were injected into the ion spray source of
a TripleTOF 5,600 quadrupole time-of-ﬂight tandem mass spectrometer (AB
SCIEX. The mass spectrometry/mass spectrometry analysis used nitrogen as the
collision gas. Data analysis was performed using the Analyst TF 1.5 software.
In vitro functional assay of GtrB activity. An assay for the activity of wild-type
and mutant GtrBSyn constructs using UDP-14C-glucose as a radiolabelled tracer
was adapted from a previously published protocol11. Brieﬂy, crude membranes
were isolated from cell lysate by centrifugation at 134,000g for 1 h and dispersed in
resuspension buffer (100 mM Tris/acetate pH 8.5) before storage at  80 °C for
later use. On the day of the assay, the membranes were thawed, resuspended by
sonication and washed two times with resuspension buffer. One milligram of crude
membranes was used for each reaction, in a ﬁnal volume of 250 ml. 1 mM EDTA,
10 mM MgCl2 and a variable (0–200 mM ﬁnal concentration) amount of UndP
(Indoﬁne Chemicals) were added to the resuspended membranes, followed by a
sonication step to facilitate incorporation of the UndP into the membrane. The
radiolabelled substrate (0.25 mM UDP-14C-glucose) was then added and the
mixture incubated at room temperature for 1 h. After extracting twice with butanol
followed by two washes with water, 180 ml of the organic phase was combined with
10 volumes of scintillation ﬂuid and radioactivity measured using a scintillation
counter (Perkin Elmer). Assays testing acceptor lipids other than UndP were
performed in the same way, with 100 mM of the alternate lipid in place of UndP.
DolP, decaprenyl phosphate, octaprenyl phosphate and hexaprenyl phosphate were
obtained from Indoﬁne Chemicals, and dodecyl phosphate and phosphatidic acid
were obtained from Sigma-Aldrich.
Alternatively, functional assays were also performed using puriﬁed protein
reconstituted into liposomes. Liposomes and proteoliposomes were prepared as
described46. Brieﬂy, E. coli polar lipid extract (Avanti) and phosphatdiylcholine
(PC, Avanti) were mixed in a 3:1 ratio (w/w) by dissolving in chloroform, and
chloroform was removed under a stream of nitrogen gas. Lipids were resuspended
in 100 mM HEPES, pH 7.5, buffer containing 1.5% (w/v) 1-O-n-Octyl-b-Dglucopyranoside (OG, Anagrade, Affymetrix) and the detergent was removed by
dialysis. The resulting liposomes were divided into aliquotes, frozen in liquid
nitrogen and stored at  80 °C. For proteoliposome formation, the concentration
of thawed liposomes was adjusted to 10 mg ml  1 and 0.11% (w/v) Triton X-100
was added to the liposome-containing solution and puriﬁed protein was then
added in a ratio of 1:80 (0.125 mg protein to 10 mg lipid), and after a 15-min
incubation, detergent was removed by the addition of Bio-Beads SM-2 (Bio-Rad).
Proteoliposomes were separated and removed from the Bio-Beads by careful
pipetting, their concentration adjusted by ultracentrifugation and resuspension in
the correct volume of buffer. Proteoliposomes were divided into aliquots, ﬂash
frozen in liquid nitrogen and stored at  80 °C. 5 mg of proteoliposomes at
10 mg ml  1 were used per assay, in a ﬁnal volume of 250 ml. All subsequent steps
were performed as described above for functional assays performed on membranes.
Assays using protoliposomes were used to test activity of G127V and T205P
GtrBSyn mutants.
Protein expression levels were normalized by quantifying the intensity of bands
on an SDS–PAGE gel, after solubilization and puriﬁcation by metal-afﬁnity
chromatography in DM, using ImageJ47. The expression levels of mutants were
compared with wild-type protein, and activity levels were then adjusted based on
this normalization.
Functional assay of human DPM1 activity in zebraﬁsh. Fertilized zebraﬁsh
(Danio rerio) oocytes were obtained from Oregon AB breeders maintained in the
Animal Research Facility at the George Washington University as described
earlier48. All animal work was performed in compliance with protocols approved
by the George Washington University Animal Care and Use Committees.
Microinjection was performed on a PLI-100A Pico-Injector (Harvard Apparatus)
at the one or two cell stage (20–45 min post fertilization) using pulled borosilicate
pipettes. MO sequences were designed by Gene Tools LLC to target the start site or
8

intron 1 splice donor site of dpm1 (ENSDART00000079591) as follows: dpm1 start
50 -TACTTCTGCGGCTCGCCATGTTGGC-30 and dpm1 splice 50 -TTCAGGTTT
CGCAATTACCTTTCGC-30 . Standard control MOs were provided by Gene Tools.
MOs were injected at 1–4 ng for dpm1 start or 8–20 ng for dpm1 splice in 1 
Danieau solution (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2,
5 mM HEPES, pH 7.6) with 0.1% phenol red as injection dye. Full-length or
mutated DPM1 mRNA was cloned into pCS2 þ for capped mRNA production.
mRNA was produced using the Ambion mMessage mMachine SP6 trascription kit.
Rescue injections were performed sequentially by injecting the MO and the mRNA
independently at the 1–2 cell stage in 60–100 embryos per condition. For each
clutch, at least four conditions were tested at the same time: un-injected wild types,
MO injection, rescue (MO þ wild-type mRNA), mutant (MO þ mutated mRNA).
Whenever sufﬁcient embryos were available, an mRNA alone control was added or
multiple mutants were tested in parallel. Embryos were maintained at 28.5 °C
and staged at hours (h) and days (d) post fertilization. For imaging and analysis
2–3 d.p.f. embryos were anaesthetized using 0.4% Tricaine stock and imaged on a
Leica M165 stereomicroscope. For knockdown quantiﬁcation, mRNA was
extracted from control and experimental embryos using Promega ReliaPrep RNA
miniprep system and reverse transcribed using Bio-Rad iScript cDNA Synthesis kit.
qPCR was performed using Bio-Rad SsoFast EvaGreen Supermix on a Bio-Rad
CFX384 platform in the GWU Biomarker Core. Expression was normalized to
ribosomal protein L8 (rpl8). Primer sequences are available in Supplementary
Table 2.
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